Mylab Nutrition | Mamacrowd

TAX Bonus

Innov STARTUP

Watch the video

Mylab Nutrition

Wellness

The personalized sports supplements. With quality raw materials produced by the best pharmaceutical laboratories.

Professional Investor

Professional Inv.

min: 100.000 €

max: 300.000 €

33 Investments

202.912 €

33 Paid

202.911 €

Minimum goal

100.000 €

Minimum Order

447,93 €

Pre-Money

1.450.000 €

30.10.2018

Closed

The content of this page has been translated automatically

Project

MyLab Nutrition is the first service in Europe for the creation of customised sports nutritional supplement formulas, providing an interactive laboratory to assist in the creation of supplement formulas and an e-commerce to purchase your own customised supplement box.

The sports supplement market has literally been exploding in recent years. We at MyLab Nutrition know our target audience well.
MyLab in fact was born from the experience accumulated with the brand T-Rex Integratori, brand owned by MyLab Nutrition srl, producer and distributor of supplements on an Italian and European scale. Born in January 2018, MyLab Nutrition with its brands (T-Rex Integrators and MyLab Nutrition) had a turnover in just 7 months of more than 75 thousand euros with a strong growth trend for both classic supplement products and customized supplements.

Today, MyLab is the only reference service that vertically focuses on the needs of the sportsman allowing him to customize his dietary supplement at 360 degrees.

The team is composed of heterogeneous figures with a strong expertise in the field of integration and with managerial, technical, commercial and marketing skills.

MyLab Nutrition has the potential to scale up on an international basis. The single-dose sachet solution allows orders to be processed and shipped in less than 24 hours.

perche-investire-thumbnail

Want to find out more about this project?

Do you already have an account?

The information on the offer is not subject to approval by Consob. The Offering company is solely responsible for the completeness and truthfulness of the data and information provided by the latter. The investor's attention is also drawn to the fact that the investment, even indirect, through OICR or companies that invest mainly in financial instruments issued by innovative startups and SMEs is illiquid and characterised by a very high risk.